Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HiCardi+ H100

K-Number: K232670 · 2024-09-20

Decision Date2024-09-20
Product CodeDSH
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

HiCardi+ H100 is the device name listed in this FDA 510(k) record. The listed applicant is MEZOO Co., Ltd.. It received FDA 510(k) clearance on 2024-09-20 under 510(k) number K232670. The device is classified under product code DSH. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HiCardi+ H100?

HiCardi+ H100 is a medical device that received FDA 510(k) clearance on 2024-09-20. The listed applicant is MEZOO Co., Ltd.. The 510(k) number is K232670.

When did HiCardi+ H100 receive FDA 510(k) clearance?

HiCardi+ H100 received FDA 510(k) clearance on 2024-09-20, under 510(k) number K232670.

Who is the listed applicant for HiCardi+ H100?

The FDA 510(k) record lists MEZOO Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HiCardi+ H100?

The FDA product code for HiCardi+ H100 is DSH.

Related Devices (Code: DSH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.